Pre-clinical comparison of approaches to increasing the immunogenicity of CA125 (MUC16) DNA vaccines

被引:0
|
作者
Ragupathi, Govind
Koide, Fusataka
Yin, Beatrice Wt
Lloyd, Kenneth O.
Hannaman, Drew
Livingston, Philip O.
机构
[1] Mem Sloan Kettering, New York, NY USA
[2] Ichor Med Syst Inc, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1406
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16
    Casey, Nicholas P.
    Kleinmanns, Katrin
    Forcados, Christopher
    Gelebart, Pascal F.
    Joaquina, Sandy
    Lode, Martine
    Benard, Emmanuelle
    Kaveh, Fatemeh
    Caulier, Benjamin
    Helgestad Gjerde, Christiane
    de Jalon, Elvira Garcia
    Warren, David J.
    Lindemann, Kristina
    Rokkones, Erik
    Davidson, Ben
    Myhre, Marit Renee
    Kvalheim, Gunnar
    Bjorge, Line
    McCormack, Emmet
    Inderberg, Else Marit
    Walchli, Sebastien
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)
  • [32] The role of the ovarian tumor marker CA125 (MUC16) in the suppression of human immune responses
    Belisle, JA
    Arens, JA
    Migneault, M
    Rancourt, C
    Felder, M
    Connor, J
    Patankar, MS
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 635 - 636
  • [33] MUC16/CA125, TNFα and IFNγ are co-expressed in malignant gynecologic neoplasms
    Morgado, Micaela
    Sutton, Margie N.
    Simmons, Mary
    Liu, Jinsong
    Lu, Zhen
    Papadopoulos, Pamela E.
    Bast, Robert C.
    Carson, Daniel D.
    CANCER RESEARCH, 2015, 75
  • [34] Molecular cloning of the CA125 ovarian cancer antigen - Identification as a new mucin, MUC16
    Yin, BWT
    Lloyd, KO
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) : 27371 - 27375
  • [35] MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis
    Theriault, Catherine
    Pinard, Maxime
    Comamala, Marina
    Migneault, Martine
    Beaudin, Julie
    Matte, Isabelle
    Boivin, Marianne
    Piche, Alain
    Rancourt, Claudine
    GYNECOLOGIC ONCOLOGY, 2011, 121 (03) : 434 - 443
  • [36] CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells
    Reinartz, Silke
    Failer, Sophie
    Schuell, Tina
    Wagner, Uwe
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (10) : 1558 - 1569
  • [37] Regulation of MUC16 (CA125) release in ovarian cancer cells by cytokines and growth factors.
    Spriggs, E
    Spriggs, C
    Thapi, D
    Awtry, C
    Spriggs, DR
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9139S - 9140S
  • [38] Integrated genomic analysis identifies PLEC1 as a molecular target of MUC16/CA125
    Blum, A.
    Tanner, E.
    Bisogna, M.
    Dao, F.
    Thapi, D.
    Spriggs, D.
    Levine, D.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S162 - S162
  • [39] Pathobiological Implications of MUC16/CA125 Expression in Intrahepatic Cholangiocarcinoma-Mass Forming Type
    Higashi, Michiyo
    Yamada, Norishige
    Yokoyama, Seiya
    Kitamoto, Sho
    Tabata, Kazuhiro
    Koriyama, Chihaya
    Batra, Surinder K.
    Yonezawa, Suguru
    PATHOBIOLOGY, 2012, 79 (02) : 101 - 106
  • [40] Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion
    Rao, Thapi D.
    Tian, Huasong
    Ma, Xun
    Yan, Xiujun
    Thapi, Sahityasri
    Schultz, Nikolaus
    Rosales, Nestor
    Monette, Sebastien
    Wang, Amy
    Hyman, David M.
    Levine, Douglas A.
    Solit, David
    Spriggs, David R.
    PLOS ONE, 2015, 10 (05):